Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis
Author Information
Author(s): David W. Dowdy, Adithya Cattamanchi, Karen R. Steingart, Madhukar Pai
Primary Institution: University of California, San Francisco
Hypothesis
Standard cost-effectiveness analyses may give misleading results when applied blindly to the scale-up of TB diagnostics.
Conclusion
To improve TB health outcomes, economic analyses should consider local conditions and the valuation of false-positive tests.
Supporting Evidence
- Standard cost-effectiveness analyses may give misleading results when applied blindly to the scale-up of TB diagnostics.
- Challenges in economic analysis of TB diagnostic tests include underestimating the cost of false-positive diagnoses.
- Flexible analytic tools are needed for decision-makers to adapt large-sample cost-effectiveness data to local conditions.
Takeaway
This study says that just looking at costs and benefits of TB tests isn't enough; we need to think about how these tests work in real life and what people really want.
Methodology
The study discusses decision analysis as a methodology for evaluating health interventions' cost-effectiveness.
Potential Biases
Bias may arise from relying on controlled studies to estimate diagnostic accuracy in field settings.
Limitations
Standard economic analyses may underestimate the costs of false-positive diagnoses and overlook operational impacts.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website